US20060263897A1 - Nanoparticles for detecting analytes - Google Patents

Nanoparticles for detecting analytes Download PDF

Info

Publication number
US20060263897A1
US20060263897A1 US10/570,444 US57044406A US2006263897A1 US 20060263897 A1 US20060263897 A1 US 20060263897A1 US 57044406 A US57044406 A US 57044406A US 2006263897 A1 US2006263897 A1 US 2006263897A1
Authority
US
United States
Prior art keywords
analyte
nanoparticle
capture probe
active
covalent bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/570,444
Other languages
English (en)
Inventor
Hendrik Stapert
Rifat Hikmet
Joukje Orsel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips Electronics NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics NV filed Critical Koninklijke Philips Electronics NV
Assigned to KONINKLIJKE PHILIPS ELECTRONICS, N.V. reassignment KONINKLIJKE PHILIPS ELECTRONICS, N.V. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ORSEL, JOUKJE GARRELINA, HIKMET, RIFAT ATA MUSTAFA, STAPERT, HENDRIK ROELOF
Publication of US20060263897A1 publication Critical patent/US20060263897A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Definitions

  • the invention relates to a device for detecting an analyte comprising a group that can form a covalent bond with the analyte and a detectable moiety.
  • the invention further relates to a method for detecting the analyte using said device, to a kit of parts containing the same, and to a calibration method using said device.
  • Nucleic acid ligand biochips have been described by Gold et al. in U.S. Pat. No. 6,242,246 and U.S. Pat. No. 6,458,543. These biochips consist of a solid support on which one or more nucleic acid ligands are attached in a spatially defined manner. Each nucleic acid ligand can form a specific and avid bond to a particular target molecule contained within a test mixture, such as a bodily fluid.
  • the target molecule can be a protein, hormone, drug, cell, chemical, and the like.
  • Nucleic acids that can bond molecules other than their complementary sequence are often called aptamers.
  • An aptamer typically contains 30-80 nucleic acids and can have a high affinity towards a certain target molecule (K d 's reported are between 10 ⁇ 11 -10 ⁇ 6 mole/l).
  • the aptamers are selected for their affinity in a so-called SELEX or PHOTOSELEX process, which was described in U.S. Pat. No. 6,482,594, U.S. Pat. No. 6,291,184, U.S. Pat. No. 6,376,190 and U.S. Pat. No. 6,458,539.
  • a typical photo-aptamer array for protein detection the following steps are usually performed: 1) incubating aptamer array and test mixture; 2) washing away test mixture (pre cross-link wash); 3) cross-linking aptamer and bonded target using 308 nm light; 4) post cross-link washing; 5) incubating array in staining solution; 6) removing staining solution; 7) detecting stain; 8) analyzing data.
  • the analytes are detected by changes in an electrical field or an electrical current generated by electrodes, or in an electrical voltage applied to an electrode or in a magnetic field, said changes being caused by marker particles, which have bonded with the analytes or by marker particles, which have instead bonded to the binding site in an electrical field.
  • marker particles may be nanoparticles, but they always bond to the analyte through an antibody that is contained on the marker particle.
  • the disadvantage of such method is that each type of analyte needs another antibody.
  • various nanoparticle-antibody complexes need to be made to bond with various analytes. It would be a considerable advantage to have nanoparticles that are not specific in this respect and can be used for any analyte, without modifying the surface of the nanoparticles.
  • the staining of proteins when using a (photo)-aptamer array is usually performed with a fluorophore that bonds chemically to the free amine groups present on the aptamer-bonded target molecule.
  • the bonding to amine functionality is especially suitable because practically no reaction will occur with (unbonded) aptamers.
  • a problem using fluorescence is the background signal that occurs due to auto-fluorescence of the array substrate.
  • the above proposed detection techniques are either not sensitive enough for detection of low amounts of bonded proteins or can not easily be miniaturized for application in cartridges for molecular diagnostics. Moreover, the hereinabove described techniques require separate calibration for every different protein.
  • Another disadvantage of the known methods is the occurrence of cross-reactivity of the different biomolecules, leading to false positive results in the detection.
  • the use of labeled biomolecules in the development step is strongly complicated by non-specific cross-reactivity of biomolecules.
  • nanoparticles for non-specific binding of analytes, allowing for their detection with high sensitivity.
  • Such nanoparticles have the additional advantage of providing a universal calibration method making separate calibration for different target molecules redundant.
  • the invention pertains to nucleic acid, polysaccharide, lipid, (modified) antibodies, (modified) protein, peptide, or hormone ligand biochips comprising a solid support on which the ligands are attached. These ligands bond specifically to particular target molecules (e.g. proteins, hormones, cells, drugs, and the like) within a test mixture.
  • target molecules e.g. proteins, hormones, cells, drugs, and the like
  • the invention relates to a device for detecting an analyte comprising a detectable moiety and a group that can form a covalent bond with the analyte, characterized in that the device is a nanoparticle and the detectable moiety is magneto-active, electro-active, or optically active.
  • the detection of the target molecules involves particles having a size in the nm- ⁇ m range, more specifically having a diameter in the range from 1 nm to 5 ⁇ m, and that are covalently bonded to, for instance, amino acids of the analytes.
  • particles having a size in the nm- ⁇ m range, more specifically having a diameter in the range from 1 nm to 5 ⁇ m, and that are covalently bonded to, for instance, amino acids of the analytes.
  • These particles (or beads) influence the surface (di)electric or magnetic properties giving rise to a change in surface properties, which can be detected by amperometric, impedimetric, magnetic, or optical methods.
  • This invention further relates to sensitive detection methods for target molecules using ligand arrays, such as nucleic acid ligand arrays. Furthermore, it is the objective of this invention to provide a universal calibration method that will directly relate the measured signal to the amount of surface bonded target molecules.
  • the surface bonded target molecule concentration can then be related to the unknown concentration of the test solution, for example using the equilibrium affinity constant (K a or K d ) of the aptamer or any other ligand, for a certain target and a surface bonding model (such as the Langmuir adsorption isotherm) that describes ligand-analyte adsorption on surfaces.
  • E-beads are particles that release electro-active molecules upon a stimulus (heat, light, chemical reaction, and the like). Bonding of surface modified E-beads (e.g. carboxylated, aminolated, biotinylated, and the like) to the ligand-bonded protein (or other analyte) can be performed as is generally known in the art. Of particular interest is the coupling of E-beads via activated esters at a suitable pH, such as about 8.5, targeting the primary amines of the protein. When the E-beads have reacted and unreacted beads have been removed, the stimulus can be applied and electro-active molecules are released into the solution.
  • a stimulus heat, light, chemical reaction, and the like.
  • Electrode preferably an interdigitated electrode with small spacing (preferably less than 100 micron, more preferably less than 20 micron, most preferably less than 2 micron) at a potential at which the electro-active species are oxidized and/or reduced resulting in a Faradaic current.
  • the electro-active species preferably is a redox recycling compound, such as p-aminophenol or quinone.
  • the interdigitated electrodes are preferably located such that contact with the test mixture is avoided thereby preventing fouling of the electrodes. This is further shown in FIG. 1 , which shows an example of an amperometric sensor design for ligand array and E-bead stains.
  • the group that can form a covalent bond with the analyte comprises at least a carboxylate, an activated ester, an acyl halide, an amine, a sulfurhydryl, an epoxy, or a hydroxy group.
  • Activated esters are known to the person of ordinary skill and include for instance a succinimide ester.
  • An advantage of the present invention is the easy detection of any analyte using the same nanoparticle.
  • the invention also relates to a method for detecting an analyte using a nanoparticle comprising a magneto-active, electro-active, or optically active group and a group that can form a covalent bond with the analyte, comprising the steps:
  • the group that can form a covalent bond with the analyte is usually another group than the magneto-active, electro-active, or optically active group, but it may be the same group, or a part thereof.
  • the capture probe is an aptamer, a peptide, a protein, an antibody, a carbohydrate, a lectin, a hormone, or a lipid. More preferably, the capture probe is attached to a solid support.
  • Amperometric detection can also be achieved when the capture probe bonded analyte is stained with an enzyme, for example horseradish peroxidase or alkaline phosphatase. After staining a substrate is added, which is transformed to a redox-active compound by the enzyme.
  • the redox-active compound preferably is a redox-recycling compound.
  • a change in the surface impedance can be measured (impedimetric detection). This change can be caused by a change of the double layer capacitance and/or of the surface potential, through the bonding of particles with a high charge density, such as gold colloids or high polarizability, such as ferro-electric particles.
  • Staining of a capture probe-bonded analyte can be performed with surface modified super paramagnetic particles. Detection of reacted particles can be performed either by GMR (Giant Magnetic Resonance) detection or by inductive methods. Suitable diameter sizes of super-paramagnetic particles are 5 nm to 3 ⁇ m, more preferably between 10 and 350 nm.
  • the surface of the particles should be modified such that cross-linking with the protein can be achieved.
  • cross-linking with the protein can be achieved.
  • Unbonded magnetic particles can be removed from the surface by applying a magnetic field such that the field gradient is away from the surface. This makes the necessity of a washing step redundant. For small magnetic particles ( ⁇ 1 micron, i.e. low magnetization) a very high field may be necessary. In this case the unreacted particles can be removed by adding larger particles that have a higher magnetization and thus can be used at lower external fields. Due to the relatively close vicinity of the larger particle, smaller particles become attracted and can thus be removed from a surface.
  • Quantum dots are small semi-conducting particles with very bright emission properties. The emission wavelength depends on the size of the quantum dots. Staining of capture probe-bonded analytes can be performed with surface modified quantum dots. For example, a CdSe/ZnS core shell particle can be modified with mercapto alkylcarboxylic acid groups, thus giving carboxylic acid functionality to the outer surface of the quantum dot. This functionality can be used for coupling to primary amine groups of the analyte.
  • the invention also pertains to a universal calibration method using nanosized particles instead of molecularly dissolved molecules (“dyes”) as a stain for e.g. aptamer bonded proteins, which gives a strong advantage in terms of calibration.
  • dyes molecularly dissolved molecules
  • a protein bonded to an aptamer will be stained with more than one dye molecule.
  • the number of bonded dye molecules will depend on the size of the protein, the efficiency of the staining reaction and the number of reactive groups on the protein. This means that the (fluorescent) signal for a certain surface concentration is different for every protein.
  • intramolecular quenching effects will add to the analyte (e.g. protein) dependent (fluorescent) signal.
  • the measured signal upon staining is the same for every aptamer-bonded protein and is only a function of surface concentration (coverage). This is possible when only one nanosized particle bonds to one protein. Therefore, universal (surface) calibration can be obtained by performing the staining reaction with particles of suitable size in such a way that only one particle will bond to one analyte.
  • the size of the particle should be such that upon bonding it will hinder other particles to bond to the said analyte, but will not hinder bonding to other bonded analyte molecules on the surface.
  • Preferred diameter sizes of the particles are between 1 and 100 nm, preferably between 3 and 25 nm. Examples of particles are luminescent quantum dots, ferro-electric particles, super-paramagnetic particles, E-beads, and gold colloids.
  • the surface bonded target molecules can then be related to the unknown concentration using for example the equilibrium affinity constant (K a or K d ) of the aptamer for a certain target and a surface bonding model (such as the Langmuir adsorption isotherm) which describes protein adsorption on aptamer modified surfaces.
  • K a or K d equilibrium affinity constant
  • a surface bonding model such as the Langmuir adsorption isotherm
  • Specific linking chemistry to allow for only one particle to bond to secondary antibodies can for example be achieved via the sugar groups of the antibody, using common methods of sugar linking chemistry.
  • the nanoparticles can be sold as a part of an assay for detecting an analyte Said nanoparticles, for instance can be combined with the biochip or other materials for detection.
  • the invention therefore also pertains to a kit of parts comprising:
  • the luminescent inorganic particles are CdS, CdTe, CdSe, ZnS, ZnSe, PbS, HgS, HgTe, GaAs, GaP, InAs, InP, and ZnO, which are round, disc like, or rod like in shape.
  • groups such as thiol, carboxylic acid, amine, or phosphine groups can be used.
  • colloidal luminescent CdSe/ZnS core-shell nanocrystals were synthesized via a two-stage approach described in D. V. Talapin, A. L. Rogach, A. Kornowski, M. Haase, and H. Weller, Nano Lett. , 1, 207 (2001)). Briefly, at the first stage the monodisperse CdSe nanocrystals were prepared by reacting dimethyl cadmium with trioctyl phosphine selenide in the hexadecyl amine-trioctyl phosphine oxide-trioctyl phosphine (HDA-TOPO-TOP) stabilizing mixture at 270-310° C.
  • HDA-TOPO-TOP trioctyl phosphine selenide
  • HDA-TOPO-TOP hexadecyl amine-trioctyl phosphine oxide-trioctyl phosphine
  • the ZnS shell around the colloidal CdSe cores was grown by slow addition of dimethyl zinc and bis-trimethyl silylsulfide (zinc and sulfur precursors, respectively) to the solution of CdSe cores in the HDA-TOPO-TOP mixture at 180-220° C. This mixture was purified by precipitation, dried, and redissolved in non-polar solution to give the quantum dot (QD) solution.
  • QD quantum dot
  • the resulting CdSe/ZnS core-shell nanocrystals were soluble in non-polar solvents like chloroform or toluene.
  • the surface of the particles was modified using e.g. mercaptopropionic acid or acetyl cysteine.
  • QD's quantum dots
  • An excess amount of thiol-containing molecules was added to the QD solution in chloroform and stirred at 50° C. for several hours. Modified QD tend to precipitate slowly upon cooling or by addition of methanol. The dissolution and precipitation steps were repeated several times in order to remove thiol-containing molecules, which were not bound to QD surfaces.
  • the resulting QDs show reasonable to good solubility in aqueous solutions.
  • the carboxylic groups on the surface of the QDs have been activated using EDC (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide) and NHS (N-hydroxy-succinimide) activation.
  • Core-shell CdSe/ZnS nanocrystals exhibit strong band-edge photoluminescence with room temperature quantum efficiencies as high as 30-70%.
  • the spectral position of the emission band is tuneable from blue to red by increasing the size of CdSe core from about 2 to 6 nm. ( FIG. 2 ).
  • a thin (about 2 monolayers) ZnS epitaxial shell grown around a CdSe core considerably improves particle stability and the luminescence efficiency.
  • FIG. 2 the emission spectra of quantum dots with a core-shell (CdSe core ZnS shell) structure are shown.
  • the emission spectra with sharp peaks were obtained using quantum dots of various sizes with a narrow size distribution. It can be seen that by changing the size of the quantum dots also the emission wavelength changes.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
US10/570,444 2003-09-09 2004-09-07 Nanoparticles for detecting analytes Abandoned US20060263897A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03103321 2003-09-09
EP03103321.0 2003-09-09
PCT/IB2004/051698 WO2005024425A1 (en) 2003-09-09 2004-09-07 Nanoparticles for detecting analytes

Publications (1)

Publication Number Publication Date
US20060263897A1 true US20060263897A1 (en) 2006-11-23

Family

ID=34259262

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/570,444 Abandoned US20060263897A1 (en) 2003-09-09 2004-09-07 Nanoparticles for detecting analytes

Country Status (4)

Country Link
US (1) US20060263897A1 (enExample)
EP (1) EP1664777A1 (enExample)
JP (1) JP2007505311A (enExample)
WO (1) WO2005024425A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080206263A1 (en) * 2007-02-16 2008-08-28 Deangelis Margaret M Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular Degeneration
US20090093381A1 (en) * 2006-12-28 2009-04-09 Wei Wang Solid phase electrochemical synthesis with controlled product cleavage
US20100261287A1 (en) * 2006-12-28 2010-10-14 Gordon Holt Method and apparatus for match quality analysis of analyte binding
WO2014123430A1 (en) * 2013-02-05 2014-08-14 Victoria Link Limited Novel bio-sensor for the detection of small molecules
US10725126B2 (en) 2016-09-05 2020-07-28 Industrial Technology Research Institute Biomolecule magnetic sensor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018113790A (ja) * 2017-01-12 2018-07-19 株式会社デンソー 太陽電池モジュール

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918004A (en) * 1984-12-24 1990-04-17 Caribbean Microparticles Corporation Method of calibrating a flow cytometer or fluorescence microscope for quantitating binding antibodies on a selected sample, and microbead calibration kit therefor
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US6242245B1 (en) * 1997-09-26 2001-06-05 Consortium für elektrochemische Industrie GmbH Multicomponent system for modifying, degrading or bleaching lignin or lignin-containing materials, and processes for its use
US6242246B1 (en) * 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6291184B1 (en) * 1990-06-11 2001-09-18 Somalogic, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US6376190B1 (en) * 2000-09-22 2002-04-23 Somalogic, Inc. Modified SELEX processes without purified protein
US6548311B1 (en) * 1997-11-21 2003-04-15 Meinhard Knoll Device and method for detecting analytes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415998D0 (en) * 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
WO1999062079A1 (en) * 1998-05-26 1999-12-02 Bar-Ilan University Nucleation and growth of magnetic metal oxide nanoparticles and its use
WO2000027365A1 (en) * 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals and their use in detection systems
FR2804117B1 (fr) * 2000-01-21 2004-08-20 Bio Merieux Procede d'isolement de proteines et/ou d'acides nucleiques, complexes de particules et de proteines et/ou d'acides nucleiques, reactif et applications
EP1215199A1 (en) * 2000-12-08 2002-06-19 Sony International (Europe) GmbH Linker molecules for selective metallisation of nucleic acids and their uses
DE10109777A1 (de) * 2001-03-01 2002-09-19 Infineon Technologies Ag Verfahren zum Erfassen von makromolekularen Biopolymeren mittels mindestens einer Einheit zum Immobilisieren von makromolekularen Biopolymeren
WO2003057175A2 (en) * 2002-01-02 2003-07-17 Visen Medical, Inc. Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
JP3897285B2 (ja) * 2002-02-05 2007-03-22 日立ソフトウエアエンジニアリング株式会社 生体高分子検出用試薬及び生体高分子検出方法
EP1481090A4 (en) * 2002-02-15 2006-08-09 Somalogic Inc METHOD AND REAGENTS FOR DETECTING BINDING OF TARGET MOLECULES BY NUCLEIC ACID ELECTRODES
US7176036B2 (en) * 2002-09-20 2007-02-13 Arrowhead Center, Inc. Electroactive microspheres and methods

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918004A (en) * 1984-12-24 1990-04-17 Caribbean Microparticles Corporation Method of calibrating a flow cytometer or fluorescence microscope for quantitating binding antibodies on a selected sample, and microbead calibration kit therefor
US6291184B1 (en) * 1990-06-11 2001-09-18 Somalogic, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US6482594B2 (en) * 1990-06-11 2002-11-19 Somalogic, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands
US5922537A (en) * 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
US6242245B1 (en) * 1997-09-26 2001-06-05 Consortium für elektrochemische Industrie GmbH Multicomponent system for modifying, degrading or bleaching lignin or lignin-containing materials, and processes for its use
US6548311B1 (en) * 1997-11-21 2003-04-15 Meinhard Knoll Device and method for detecting analytes
US6242246B1 (en) * 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6458543B1 (en) * 1997-12-15 2002-10-01 Somalogic, Incorporated Nucleic acid ligand diagnostic biochip
US6376190B1 (en) * 2000-09-22 2002-04-23 Somalogic, Inc. Modified SELEX processes without purified protein

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150212032A1 (en) * 2006-12-28 2015-07-30 Intel Corporation Method and apparatus for match quality analysis of analyte binding
US20090093381A1 (en) * 2006-12-28 2009-04-09 Wei Wang Solid phase electrochemical synthesis with controlled product cleavage
US20100261287A1 (en) * 2006-12-28 2010-10-14 Gordon Holt Method and apparatus for match quality analysis of analyte binding
US8603803B2 (en) 2006-12-28 2013-12-10 Intel Corporation Solid phase electrochemical synthesis with controlled product cleavage
US8647821B2 (en) 2006-12-28 2014-02-11 Intel Corporation Method and apparatus for combined electrochemical synthesis and detection of analytes
US8999724B2 (en) * 2006-12-28 2015-04-07 Intel Corporation Method and apparatus for match quality analysis of analyte binding
US7972787B2 (en) 2007-02-16 2011-07-05 Massachusetts Eye And Ear Infirmary Methods for detecting age-related macular degeneration
US8232056B2 (en) 2007-02-16 2012-07-31 Massachusetts Eye And Ear Infirmary Methods for detecting neovascular age-related macular degeneration
US20080206263A1 (en) * 2007-02-16 2008-08-28 Deangelis Margaret M Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular Degeneration
WO2014123430A1 (en) * 2013-02-05 2014-08-14 Victoria Link Limited Novel bio-sensor for the detection of small molecules
JP2016507063A (ja) * 2013-02-05 2016-03-07 ヴィクトリア リンク リミテッド 小分子を検出するための新規バイオセンサー
US10023869B2 (en) 2013-02-05 2018-07-17 Auramer Bio Limited Bio-sensor for the detection of small molecules
US10725126B2 (en) 2016-09-05 2020-07-28 Industrial Technology Research Institute Biomolecule magnetic sensor

Also Published As

Publication number Publication date
WO2005024425A1 (en) 2005-03-17
JP2007505311A (ja) 2007-03-08
EP1664777A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
US8092859B2 (en) Synthesis of highly luminescent colloidal particles
US6872450B2 (en) Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same
Petryayeva et al. Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging
US20060246524A1 (en) Nanoparticle conjugates
Esteve-Turrillas et al. Applications of quantum dots as probes in immunosensing of small-sized analytes
Tyrakowski et al. A primer on the synthesis, water-solubilization, and functionalization of quantum dots, their use as biological sensing agents, and present status
AU2003247788B2 (en) Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
CN110763834B (zh) 一种检测免疫标志物含量的方法、试剂和试剂盒
US7101718B2 (en) Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
KR101195957B1 (ko) 표면증강 라만 산란 복합 프로브 및 이를 이용하여 표적 물질을 검출하는 방법
CN107787352A (zh) 连续发射的核/壳纳米片
US20030059955A1 (en) Affinity tag modified particles
Carvalho et al. Fluorescence plate reader for quantum dot-protein bioconjugation analysis
US20060263897A1 (en) Nanoparticles for detecting analytes
EP2769403B1 (en) Improved biomarkers and use thereof
US20090186419A1 (en) Luminescent Metal Oxide Films
JP2010002393A (ja) 標的物質の検出方法
Gai et al. Digital Immunoassays
KR20120083178A (ko) 면역 센서에서 검출 신호를 증폭하기 위한 키트 및 이를 이용한 표적 항원의 검출 방법
Ahmed Use of Nanotechnology for Enhancing of Cancer Biomarker Discovery and Analysis: A Molecular Approach
Huang et al. Simultaneous Detection of Multi-DNAs and Antigens Based on Self-Assembly of Quantum Dots and Carbon Nanotubes
Pompa et al. Fluorescent Nanocrystals and Proteins
Lofton et al. Lin Wang
AU2002335695A1 (en) Affinity tag modified particles

Legal Events

Date Code Title Description
AS Assignment

Owner name: KONINKLIJKE PHILIPS ELECTRONICS, N.V., NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STAPERT, HENDRIK ROELOF;HIKMET, RIFAT ATA MUSTAFA;ORSEL, JOUKJE GARRELINA;REEL/FRAME:017710/0166;SIGNING DATES FROM 20050405 TO 20050407

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION